Gavin Corcoran
CIK 1745995 · Chief R&D Officer · last filed 2026-06-09
Gavin Corcoran is a Chief R&D Officer who has filed 10 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for VRCA, was dated Jun 9, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
10
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRCA | Director | — | $5.73 | — | $0 | 3 | 2026-06-09 |
| Sio Gene Therapies Inc. (SIOX) Delisted | Chief R&D Officer | 25,792 | $0.48 | $12.3K | $0 | 2 | 2021-04-19 |
| Sio Gene Therapies Inc. (AXGT) Delisted | Chief R&D Officer | 16,002 | — | — | $0 | 3 | 2020-06-15 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | VRCA | Grant (A) | — | $0 | EDGAR |
| 2021-04-19 | Sio Gene Therapies Inc. (SIOX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-19 | Sio Gene Therapies Inc. (SIOX) Delisted | Mixed | +16,001 | $0 | EDGAR |
| 2020-06-15 | Sio Gene Therapies Inc. (AXGT) Delisted | Mixed | +9,791 | -$21.5K | EDGAR |
| 2020-04-17 | Sio Gene Therapies Inc. (AXGT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-24 | Sio Gene Therapies Inc. (AXGT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | — | Grant (A) | — | $0 | |
| 2018-07-20 | — | Grant (A) | — | $0 |